Literature DB >> 2898700

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure.

Y Muto1, K T Nouri-Aria, A Meager, G J Alexander, A L Eddleston, R Williams.   

Abstract

Sepsis and endotoxaemia are common in fulminant hepatic failure (FHF) and may contribute to multisystem disease in such patients. Tumour necrosis factor (TNF) is a probable mediator of endotoxic shock and infusion of this monokine into animals causes multi-organ failure that shares features with FHF. In patients with FHF, TNF production was increased and correlated closely with activity of interleukin-1, another cytokine that is released by monocytes/macrophages in response to infection and endotoxin and is produced in increased quantities in FHF. Interleukin-2 activity was impaired in FHF and correlated negatively with TNF production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898700     DOI: 10.1016/s0140-6736(88)90006-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  66 in total

1.  Segmental Differences in Radiation-Induced Alterations of Tight Junction-Related Proteins in Non-Human Primate Jejunum, Ileum and Colon.

Authors:  Sarita Garg; Junying Zheng; Junru Wang; Simon Authier; Mylene Pouliot; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2015-12-31       Impact factor: 2.841

Review 2.  Liver regeneration in relationship to acute liver failure.

Authors:  C D Gove; R D Hughes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.

Authors:  Bulent Yildirim; Ramazan Sari; Nuran Isci
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

4.  Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxin.

Authors:  Y Shiratori; H Moriwaki; Y Muto; H Onishi; M Kato; F Asano
Journal:  Gastroenterol Jpn       Date:  1989-12

5.  Potential role of tumor necrosis factor (TNF) in an experimental model of massive liver necrosis.

Authors:  H Ohnishi; R Pei; Y Muto; H Moriwaki; K Nagura
Journal:  Gastroenterol Jpn       Date:  1989-02

6.  Abnormal immunity and gene mutation in patients with severe hepatitis-B.

Authors:  Jing-Yan Wang; Pei Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production.

Authors:  N Ikeda; N Mukaida; S Kaneko; N Fujioka; S Su; H Nariuchi; M Unoura; K Harada; Y Nakanuma; K Kobayashi
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice.

Authors:  P Liu; H Ohnishi; H Moriwaki; Y Muto
Journal:  Gastroenterol Jpn       Date:  1990-06

9.  TNFalpha is required for cholestasis-induced liver fibrosis in the mouse.

Authors:  Erwin Gäbele; Matthias Froh; Gavin E Arteel; Takehiko Uesugi; Claus Hellerbrand; Jürgen Schölmerich; David A Brenner; Ronald G Thurman; Richard A Rippe
Journal:  Biochem Biophys Res Commun       Date:  2008-11-06       Impact factor: 3.575

10.  Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome.

Authors:  B E Corkey; J F Geschwind; J T Deeney; D E Hale; S D Douglas; L Kilpatrick
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.